Reply: Cautious interpretation of the association between finite treatment and better prognosis in patients with cirrhosis who are initially HBeAg-negative and have hepatitis B
Author:
Affiliation:
1. College of Medicine, Chang Gung University, Taipei, Taiwan
2. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan
3. Liver Research Unit, Chang Gung Memorial Hospital, Taiwan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hepatology
Reference5 articles.
1. Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis;Deng;Hepatology,2023
2. Hepatocellular carcinoma reduced, HBsAg loss increased and survival improved after finite therapy in hepatitis B patients with cirrhosis;Jeng;Hepatology,2023
3. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update;Liaw;Hepatol Int,2012
4. Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment;Kim;Hepatology,2017
5. Medication nonadherence increases hepatocellular carcinoma, cirrhotic complications, and mortality in chronic Hepatitis B patients treated with entecavir;Shin;Am J Gastroenterol,2018
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Reply: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?;Hepatology;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3